Express Pharma

Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData

Deal value decreased by 89 per cent in Jan 2021, compared to Dec 2020

0 657

In January 2021, the healthcare industry reported 70 deals worth $6.2 billion as compared to last 12-month average (January 2020 to December 2020) of 87 deals worth $17.1 billion.

Sanofi, a pharma company to acquire Kymab, a clinical-stage biopharma company focusing on developing fully human monoclonal antibody therapeutics for approximately $1.4 billion; Angelini Pharma, a pharma company to acquire Arvelle Therapeutics, a biopharma company for $960 million; Thermo Fisher Scientific, to acquire Henogen S.A., a biotech company for $880.8 million and Nordic Capital, to acquire Advanz Pharma Corp, a pharma company for $846 million were some of the major deals that contributed 66 per cent of the total deal value during January 2021.

Deal Date

Acquirer (s)

Target

Deal Value ($ m)

11-Jan-21

Sanofi (France)

Kymab Ltd (UK)

1,450.0

4-Jan-21

Angelini Spa (Italy)

Arvelle Therapeutics GmbH (Switzerland)

960.0

15-Jan-21

Thermo Fisher Scientific Inc (US)

Henogen S.A. (Belgium)

880.8